Multicenter, Randomized, Phase III Study of a Single Dose of IncobotulinumtoxinA, Free from Complexing Proteins, in the Treatment of Glabellar Frown Lines

Author： Carruthers Alastair   Carruthers Jean   Coleman William P.   Donofrio Lisa   Flynn Timothy   Gold Michael   Heinz Moritz   Harrington Laura   Jones Derek   McDaniel David   Rohrer Thomas   Schlöbe Andrea   Solish Nowell   Weiss Robert A.  

Publisher： Elsevier

ISSN： 1076-0512

Source： Dermatologic Surgery, Vol.39, Iss.4, 2013-04, pp. : 551-558

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Randomized, Placebo-Controlled, Double-Blind Phase III Trial Investigating the Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Glabellar Frown Lines Using a Stringent Composite Endpoint

By William Hanke C.   Narins Rhoda S.   Brandt Fredric   Cohen Joel L.   Donofrio Lisa M.   Downie Jeanine   Heinz Moritz   Harrington Laura   McDaniel David H.   Nestor Mark   Schlessinger Joel   Schlöbe Andrea   Taub Amy   Weiss Robert A.  

Dermatologic Surgery, Vol. 39, Iss. 6, 2013-06 ,pp. : 891-899

Elsevier

Access to resources Recommend Favorite

Evaluation of the Dose-Response Relationship of Amlodipine and Losartan Combination in Patients with Essential Hypertension: An 8-Week, Randomized, Double-Blind, Factorial, Phase II, Multicenter Study

By Park Chang-Gyu  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 1, 2012-02 ,pp. : 35-47

Adis International

Access to resources Recommend Favorite

Effects of Varying Degrees of Renal Impairment on the Pharmacokinetics of Duloxetine: Analysis of a Single-Dose Phase I Study and Pooled Steady-State Data from Phase II/III Trials

By Lobo Evelyn D.  

Clinical Pharmacokinetics, Vol. 49, Iss. 5, 2010-05 ,pp. : 311-321

Adis International

Access to resources Recommend Favorite

Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study

By Isik AZ   Caglar GS   Sozen E   Akarsu C   Tuncay G   Ozbıcer T   Vicdan K  

Reproductive BioMedicine Online, Vol. 19, Iss. 4, 2009-10 ,pp. : 472-477

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Time to Onset of Response of AbobotulinumtoxinA in the Treatment of Glabellar Lines: A Subset Analysis of Phase 3 Clinical Trials of a New Botulinum Toxin Type A

By SCHLESSINGER JOEL   MONHEIT GARY   KANE MICHAEL A.C.   MENDELSOHN NAOMI  

Dermatologic Surgery, Vol. 37, Iss. 10, 2011-10 ,pp. : 1434-1442

Elsevier

Access to resources Recommend Favorite